What question did this study set out to answer?

This research aims to evaluate the prevalence of hypertension and implications of the 2017 ACC/AHA guidelines for antihypertensive medication in U.S. adults.

November 13, 2017CirculationOpen Access

Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline

View Full Paper

Ask AI

Bookmark

Why the study?

What is the impact of the 2017 ACC/AHA High Blood Pressure Guideline on the prevalence of hypertension and medication recommendations compared to JNC7 in US adults?

Key Points

This research aims to evaluate the prevalence of hypertension and implications of the 2017 ACC/AHA guidelines for antihypertensive medication in U.S. adults.
Analyzed data from the 2011 to 2014 National Health and Nutrition Examination Survey (N=9,623).
Blood pressure (BP) was measured three times using a standardized protocol and averaged.
Results were weighted to yield U.S. population estimates.
The crude prevalence of hypertension was 45.6% according to 2017 ACC/AHA guidelines (95% CI: 43.6% to 47.6%) and 31.9% according to JNC7 (95% CI: 30.1% to 33.7%).
Antihypertensive medication was recommended for 36.2% of U.S. adults per ACC/AHA guidelines (95% CI: 34.2% to 38.2%).
Among those taking antihypertensive medication, 53.4% had BP above treatment goals with 2017 ACC/AHA guidelines (95% CI: 49.9% to 56.8%).

Structured PICO

What is the impact of the 2017 ACC/AHA High Blood Pressure Guideline on the prevalence of hypertension and medication recommendations compared to JNC7 in US adults?

Population

9,623 U.S. adults from the 2011 to 2014 National Health and Nutrition Examination Survey (NHANES)

Intervention

Application of the 2017 ACC/AHA High Blood Pressure Guideline criteria

Comparator

Application of the JNC7 guideline criteria

Outcome

Prevalence of hypertension, percentage recommended for antihypertensive medication, and percentage with BP above treatment goal

The 2017 ACC/AHA hypertension guideline substantially increases the proportion of US adults diagnosed with hypertension but only slightly increases the proportion recommended for pharmacological treatment compared to JNC7.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Alerts clinicians to higher hypertension diagnoses with minimal added treatment eligibility; extends prevalence estimates but leaves outcome implications open.

Cite This Study

Muntner et al. (2017) studied this question.

synapsesocial.com/papers/69f4434956912cbbf429a27d https://doi.org/10.1161/circulationaha.117.032582

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Implication

Alerts clinicians to higher hypertension diagnoses with minimal added treatment eligibility; extends prevalence estimates but leaves outcome implications open.

Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider